These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11790757)

  • 1. Molecular and physical characterization of Burkholderia mallei O antigens.
    Burtnick MN; Brett PJ; Woods DE
    J Bacteriol; 2002 Feb; 184(3):849-52. PubMed ID: 11790757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic relatedness between Burkholderia pseudomallei and Burkholderia mallei.
    Anuntagool N; Sirisinha S
    Microbiol Immunol; 2002; 46(3):143-50. PubMed ID: 12008922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.
    Moustafa DA; Scarff JM; Garcia PP; Cassidy SK; DiGiandomenico A; Waag DM; Inzana TJ; Goldberg JB
    PLoS One; 2015; 10(7):e0132032. PubMed ID: 26148026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The wbiA locus is required for the 2-O-acetylation of lipopolysaccharides expressed by Burkholderia pseudomallei and Burkholderia thailandensis.
    Brett PJ; Burtnick MN; Woods DE
    FEMS Microbiol Lett; 2003 Jan; 218(2):323-8. PubMed ID: 12586411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of mouse hybridomas for production of monoclonal antibodies specific to Burkholderia mallei and Burkholderia pseudomallei.
    Feng SH; Tsai S; Rodriguez J; Newsome T; Emanuel P; Lo SC
    Hybridoma (Larchmt); 2006 Aug; 25(4):193-201. PubMed ID: 16934015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burkholderia thailandensis oacA mutants facilitate the expression of Burkholderia mallei-like O polysaccharides.
    Brett PJ; Burtnick MN; Heiss C; Azadi P; DeShazer D; Woods DE; Gherardini FC
    Infect Immun; 2011 Feb; 79(2):961-9. PubMed ID: 21115721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharides from Different
    Sengyee S; Yoon SH; West TE; Ernst RK; Chantratita N
    Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31548320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polysaccharides and virulence of Burkholderia pseudomallei.
    Sarkar-Tyson M; Thwaite JE; Harding SV; Smither SJ; Oyston PCF; Atkins TP; Titball RW
    J Med Microbiol; 2007 Aug; 56(Pt 8):1005-1010. PubMed ID: 17644705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies.
    Ho M; Schollaardt T; Smith MD; Perry MB; Brett PJ; Chaowagul W; Bryan LE
    Infect Immun; 1997 Sep; 65(9):3648-53. PubMed ID: 9284132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Burkholderia pseudomallei O-antigen serotypes in near-neighbor species.
    Stone JK; Mayo M; Grasso SA; Ginther JL; Warrington SD; Allender CJ; Doyle A; Georgia S; Kaestli M; Broomall SM; Karavis MA; Insalaco JM; Hubbard KS; McNew LA; Gibbons HS; Currie BJ; Keim P; Tuanyok A
    BMC Microbiol; 2012 Nov; 12():250. PubMed ID: 23126230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid multiplex immunofluorescent assay to detect antibodies against Burkholderia pseudomallei and taxonomically closely related nonfermenters.
    Iihara H; Niwa T; Shah MM; Nhung PH; Song SX; Hayashi M; Ohkusa K; Itoh Y; Makino S; Ezaki T
    Jpn J Infect Dis; 2007 Jul; 60(4):230-4. PubMed ID: 17642542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro and In Vivo studies of monoclonal antibodies with prominent bactericidal activity against Burkholderia pseudomallei and Burkholderia mallei.
    Zhang S; Feng SH; Li B; Kim HY; Rodriguez J; Tsai S; Lo SC
    Clin Vaccine Immunol; 2011 May; 18(5):825-34. PubMed ID: 21450976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and molecular characterization of mouse single-chain variable fragment antibodies against Burkholderia mallei and Burkholderia pseudomallei.
    Kim HS; Tsai S; Zou N; Lo SC; Wear DJ; Izadjoo MJ
    J Immunol Methods; 2011 Feb; 365(1-2):101-9. PubMed ID: 21172353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunobiological properties of Burkholderia pseudomallei and Burkholderia mallei capsular substances].
    Popov SF; Tikhonov NG; Piven' NN; Avrorova IV; Viktorov DV; Kurilov VIa
    Zh Mikrobiol Epidemiol Immunobiol; 2002; (6):60-4. PubMed ID: 12506631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between antigenicity and pathogenicity for Burkholderia pseudomallei and Burkholderia mallei revealed by a large panel of mouse MAbs.
    Zou N; Tsai S; Feng SH; Newsome T; Kim HY; Li B; Zhang S; Lo SC
    Hybridoma (Larchmt); 2008 Aug; 27(4):231-40. PubMed ID: 18707541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence.
    DeShazer D; Brett PJ; Woods DE
    Mol Microbiol; 1998 Dec; 30(5):1081-100. PubMed ID: 9988483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural characterization of the lipopolysaccharide O antigens of Burkholderia pseudomallei.
    Perry MB; MacLean LL; Schollaardt T; Bryan LE; Ho M
    Infect Immun; 1995 Sep; 63(9):3348-52. PubMed ID: 7543882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melioidosis patient serum-reactive synthetic tetrasaccharides bearing the predominant epitopes of Burkholderia pseudomallei and Burkholderia mallei O-antigens.
    Cloutier M; Delar E; Muru K; Ndong S; Hoyeck RR; Kaewarpai T; Chantratita N; Burtnick MN; Brett PJ; Gauthier C
    Org Biomol Chem; 2019 Oct; 17(39):8878-8901. PubMed ID: 31513223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human single-chain Fv antibodies against Burkholderia mallei and Burkholderia pseudomallei.
    Zou N; Newsome T; Li B; Tsai S; Lo SC
    Exp Biol Med (Maywood); 2007 Apr; 232(4):550-6. PubMed ID: 17392491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of novel O-polysaccharide based glycoconjugates for immunization against glanders.
    Burtnick MN; Heiss C; Schuler AM; Azadi P; Brett PJ
    Front Cell Infect Microbiol; 2012; 2():148. PubMed ID: 23205347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.